Search results for "ch%u1ea1y spin coin master mi%u1ec5n ph%u00ed wpk%u4ff1%u4e50%u90e8%u6709%u5916%u6302%u5417 wepoker%u4ff1%u4e50%u90e8(%u4e86%u89e3 %u7ef4:%u98de%u673a%u5ba2%u670d%u641c%uff1a@altes007 %u7535%u62a5%u5165%u7fa4%u641c @wpk010)%u9ebb%u5c06%u900f%u89c6%u4f5c%u5f0a%u5668/%u5fb7%u5dde%u6251%u514b%u900f%u89c6%u5916%u6302/%u5fb7%u6251%u4e4b%u661f%u4f5c%u5f0a%u5668%u5fae%u6251%u514b%u5916%u6302/%u5fb7%u5dde%u6251%u514b%u8f85%u52a9%u5668%u5916%u6302/wpk%u900f%u89c6%u6302%u8f85%u52a9 c%u00e1ch ch%u1ea1y spin coin master 2023 .zfv"
318 results found
National Patient Safety Alert – NatPSA/2023/005/MHRA
Removal of Philips Health Systems V60 and V60 Plus ventilators from service – potential unexpected shutdown leading to complete loss of ventilation
National Patient Safety Alert – NatPSA/2023/003/MHRA
NatPSA/2023/003/MHRA - NIDEK EyeCee One preloaded and EyeCee One Crystal preloaded Intraocular Lenses (IOLs): risk of increased intraocular pressure
National Patient Safety Alert – NatPSA/2023/001/NHSPS
NatPSA/2023/001/NHSPS - Use of oxygen cylinders where patients do not have access to medical gas pipeline systems
Statement of Financial Entitlement (SFE)
Annual Scottish Government publication for the General Medical Services contract.
Water safety (SHTM 2027, SHTM 2040 and SHTM 04-01 ARCHIVED)
(Archived) Scottish Health Technical Memorandum 04-01 Parts A, B, C, D, E F and G: water safety for healthcare premises.
FOI – 2023-000179 Amount Spent On Transgender Related Treatments Each Year
Information request and response for FOI Reference: FOI – 2023-000179
FOI – 2023-000254 NP50022 Temporary Agency Medical Locum Doctors
Information request and response for FOI Reference: FOI – 2023-000253
FOI – 2023-000099 All documents attached to the "SPATH – Sub group considerations and recommendations v1"
Information request and response for FOI Reference: FOI – 2023-000099
FOI – 2023-000201 Transgender-related treatment costs per individual
Information request and response for FOI Reference: FOI – 2023-000201
FOI – 2024-000050 - Fibrinogen and Plasma Products
Information request and response for FOI Reference: FOI – 2023-000050